ABVC BioPharma, Inc.
Income Statement
| Line Item | FY2010 |
|---|---|
| Revenue | $14.9K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | — |
| SG&A Expense | $1.9M |
| Operating Income | $-1.9M |
| Operating Margin | -12,715.2% |
| Interest Expense | $-218.6K |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-1.9M |
| Net Margin | -12,793.1% |
| EPS (Basic) | $0.00 |
| EPS (Diluted) | $0.00 |
| Shares Outstanding (Basic) | 345.78B |
| Shares Outstanding (Diluted) | 345.78B |
| Dividends Per Share | — |